Inventor · disambiguated record
Michel Morre
Also filed as: MORRE MICHEL · MORRE MICHEL CHRISTIAN
9 granted patents·3 pending applications·314 citations·filing 1982–2015
91Inventor score
Top patents by PatentIndex Score
12 records- 0196US4478836A1-Aryl 2-aminomethyl cyclopropane carboxyamide (Z) derivatives and their use as useful drugs in the treatment of disturbances of the central nervous systemFABRE SA PIERRE·Filed 1982·Granted Oct 23, 1984·118 cites·16 claims
- 0289US7708985B2Glycosylated IL-7, preparation and usesCYTHERIS·Filed 2006·Granted May 4, 2010·22 cites·13 claims
- 0388US5017613AValproic acid preparationsSANOFI SA·Filed 1989·Granted May 21, 1991·59 cites·3 claims
- 0486US8153114B2Hyperglycosylated mammalian IL-7 IgG conjugate compositionMORRE MICHEL·Filed 2011·Granted Apr 10, 2012·18 cites·17 claims
- 0586US8034327B2Hyperglycosylated IL-7, preparation and usesCYTHERIS·Filed 2010·Granted Oct 11, 2011·12 cites·14 claims
- 0681US7585947B2IL-7 drug substance, composition, preparation and usesCYTHERIS·Filed 2003·Granted Sep 8, 2009·25 cites·42 claims
- 0765US5185159APharmaceutical composition based on valproic acid and a process for preparing itSANOFI SA·Filed 1991·Granted Feb 9, 1993·34 cites·6 claims
- 0865US4788188AQuinolylglycinamide derivatives, the process for preparation thereof and their therapeutic application as psychotropic drugsSANOFI SA·Filed 1986·Granted Nov 29, 1988·13 cites·10 claims
- 0955US6713053B1Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particularSANOFI SYNTHELABO·Filed 1997·Granted Mar 30, 2004·13 cites·1 claims
- 1045US2004180037A1Use of IL-7 for treating autoimmune diseases, in particular insulin-dependent diabetes mellitusFiled 2004·Application pending·0 cites
- 1136US2014377218A1Hcv immunotherapyMORRE MICHEL·Filed 2012·Application pending·0 cites
- 1236US2018028593A1Terminal nanofiltration of solubilized protein compositions for removal of immunogenic aggregatesBOREAL INVEST·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →